AbCellera Biologics
ABCL
ABCL
128 hedge funds and large institutions have $279M invested in AbCellera Biologics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 50 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 50
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
128
Holding in Top 10
–
Calls
$682K
Puts
$927K
Top Buyers
| 1 | +$24.9M | |
| 2 | +$12.1M | |
| 3 | +$6.93M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.71M |
| 5 |
Renaissance Technologies
New York
|
+$908K |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$2.83M | |
| 3 | -$2.32M | |
| 4 |
Millennium Management
New York
|
-$1.37M |
| 5 |
BlackRock
New York
|
-$1.16M |